Literature DB >> 23270779

Cobalt derivatives as promising therapeutic agents.

Marie C Heffern1, Natsuho Yamamoto, Robert J Holbrook, Amanda L Eckermann, Thomas J Meade.   

Abstract

Inorganic complexes are versatile platforms for the development of potent and selective pharmaceutical agents. Cobalt possesses a diverse array of properties that can be manipulated to yield promising drug candidates. Investigations into the mechanism of cobalt therapeutic agents can provide valuable insight into the physicochemical properties that can be harnessed for drug development. This review presents examples of bioactive cobalt complexes with special attention to their mechanisms of action. Specifically, cobalt complexes that elicit biological effects through protein inhibition, modification of drug activity, and bioreductive activation are discussed. Insights gained from these examples reveal features of cobalt that can be rationally tuned to produce therapeutics with high specificity and improved efficacy for the biomolecule or pathway of interest.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270779      PMCID: PMC3622775          DOI: 10.1016/j.cbpa.2012.11.019

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  48 in total

Review 1.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

Review 2.  DNA-binding small molecules as inhibitors of transcription factors.

Authors:  Chung-Hang Leung; Daniel Shiu-Hin Chan; Victor Pui-Yan Ma; Dik-Lung Ma
Journal:  Med Res Rev       Date:  2012-04-30       Impact factor: 12.944

3.  Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes.

Authors:  Filitsa Dimiza; Athanasios N Papadopoulos; Vassilis Tangoulis; Vassilis Psycharis; Catherine P Raptopoulou; Dimitris P Kessissoglou; George Psomas
Journal:  Dalton Trans       Date:  2010-05-21       Impact factor: 4.390

4.  A new Co(III)-hypocrellin B complex with enhanced photonuclease activity.

Authors:  Yi Sun; Yuan-Jun Hou; Qian-Xiong Zhou; Jing-Rong Chen; Bao-Wen Zhang; Xue-Song Wang
Journal:  J Inorg Biochem       Date:  2011-04-05       Impact factor: 4.155

5.  Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins.

Authors:  D C Ware; H R Palmer; P J Brothers; C E Rickard; W R Wilson; W A Denny
Journal:  J Inorg Biochem       Date:  1997-11-15       Impact factor: 4.155

6.  Synthesis, characterization, DNA binding properties, fluorescence studies and toxic activity of cobalt(III) and ruthenium(II) polypyridyl complexes.

Authors:  Penumaka Nagababu; Mynam Shilpa; J Naveena Lavanya Latha; Ira Bhatnagar; P N B S Srinivas; Yata Praveen Kumar; Kotha Laxma Reddy; Sirasani Satyanarayana
Journal:  J Fluoresc       Date:  2010-10-08       Impact factor: 2.217

7.  Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96.

Authors:  J A Schwartz; E K Lium; S J Silverstein
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs.

Authors:  G-One Ahn; David C Ware; William A Denny; William R Wilson
Journal:  Radiat Res       Date:  2004-09       Impact factor: 2.841

9.  Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.

Authors:  W R Wilson; J W Moselen; S Cliffe; W A Denny; D C Ware
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-05-15       Impact factor: 7.038

10.  A cobalt complex that selectively disrupts the structure and function of zinc fingers.

Authors:  A Y Louie; T J Meade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  23 in total

1.  Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Josh W Kurutz; Thomas J Meade
Journal:  Chemistry       Date:  2013-11-06       Impact factor: 5.236

2.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

3.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

4.  Zinc and iron complexes of oleanolic acid, (OA) attenuate allergic airway inflammation in rats.

Authors:  Adnan Jehangir; Muhammad Shahzad; Khadija Shahid; Akbar Waheed; Farhana Ayub
Journal:  Inflammopharmacology       Date:  2019-05-08       Impact factor: 4.473

5.  Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Pauline T Velasco; Lauren M Matosziuk; Joseph L Coomes; Constantine Karras; Mark A Ratner; William L Klein; Amanda L Eckermann; Thomas J Meade
Journal:  Chembiochem       Date:  2014-06-24       Impact factor: 3.164

6.  Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate.

Authors:  Luke F Vistain; Natsuho Yamamoto; Richa Rathore; Peter Cha; Thomas J Meade
Journal:  Chembiochem       Date:  2015-08-25       Impact factor: 3.164

7.  Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand.

Authors:  Hana Crlikova; Hana Kostrhunova; Jitka Pracharova; Máté Kozsup; Sándor Nagy; Péter Buglyó; Viktor Brabec; Jana Kasparkova
Journal:  J Biol Inorg Chem       Date:  2020-02-28       Impact factor: 3.358

8.  Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.

Authors:  Mark D Peterson; Robert J Holbrook; Thomas J Meade; Emily A Weiss
Journal:  J Am Chem Soc       Date:  2013-08-23       Impact factor: 15.419

9.  A novel Schiff base cobalt(III) complex induces a synergistic effect on cervical cancer cells by arresting early apoptosis stage.

Authors:  Wen-Hui Liao; Xue-Qing Song; Yan-Jie Kong; Rui-Dan Bao; Fang-Fang Li; Jie Zhou; Qi-Hua Zhao; Jing-Yuan Xu; Ni Xie; Ming-Jin Xie
Journal:  Biometals       Date:  2021-01-03       Impact factor: 2.949

10.  Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation.

Authors:  Claudia Karnthaler-Benbakka; Diana Groza; Kushtrim Kryeziu; Verena Pichler; Alexander Roller; Walter Berger; Petra Heffeter; Christian R Kowol
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-30       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.